Erica Forsberg is Vice President Metabolomics at Bruker Daltonics and manages the metabolomics business for Bruker Life Sciences Mass Spectrometry. She came to Bruker in 2021 from a faculty position in the Department of Chemistry at San Diego State University following a post-doctoral fellowship at The Scripps Research Institute in Gary Siuzdak’s group. Her major focus has been untargeted metabolomics method development and bioinformatics solutions for structure elucidation. Her current role involves managing the development and implementation of Bruker’s future metabolomics and lipidomics solutions.
Metabolomics Meets Machine Learning: The Future of Nature-Inspired Drug Discovery
March 29th 2024Researchers at Enveda Biosciences are transforming nature into new medicines with their artificial intelligence (AI)-enabled industrial-scale drug discovery platform incorporating tandem mass spectrometry (MS/MS).